hamburger menu
All Coursesall course arrow
adda247
reward-icon
adda247
    arrow
    arrow
    arrow
    In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
    Question

    In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:

    A.

    Retroviral vector is introduced into these lymphocytes.

    B.

    Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages

    C.

    Lymphocytes from patient's blood are grown in culture, outside the body.

    D.

    Genetically engineered lymphocytes are not immortal cells.

    Correct option is D

    Free Tests

    Free
    Must Attempt

    NBTS 2024 Full Syllabus 01

    languageIcon English
    • pdpQsnIcon200 Questions
    • pdpsheetsIcon720 Marks
    • timerIcon200 Mins
    languageIcon English
    Free
    Must Attempt

    Samarthan Test Series : Complete Class 11th + 12th Syllabus Full Syllabus 01

    languageIcon English
    • pdpQsnIcon200 Questions
    • pdpsheetsIcon720 Marks
    • timerIcon200 Mins
    languageIcon English